Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

16:38
09/19/17
09/19
16:38
09/19/17
16:38

Iovance Biotherapeutics files to sell $50M of common stock

Jefferies and Wells Fargo Securities are acting as joint book-running managers for the offering and Oppenheimer & Co. is acting as the lead manager.

  • 25

    Sep

IOVA Iovance Biotherapeutics
$8.55

0.3 (3.64%)

08/03/17
OPCO
08/03/17
INITIATION
Target $13
OPCO
Outperform
Iovance Biotherapeutics initiated with an Outperform at Oppenheimer
Oppenheimer analyst Mark Breidenbach initiated Iovance Biotherapeutics with an Outperform and a $13 price target saying its tumor infiltrating lymphocytes therapy has been clinically validated by several academic institutions and expects to see a stream of clinical readouts from three ongoing company-sponsored trials in the next 12-18 month. Breidenbach expects lovance's path to commercialization in solid tumors to be simplified due to to the trailblazing of personalized CAR-T therapies for blood cancers.
08/31/17
HCWC
08/31/17
NO CHANGE
Target $16
HCWC
Buy
Iovance 'fired another shot across the bow of CAR-Ts,' says H.C. Wainwright
The approval of Novartis' (NVS) Kymriah is a "major leap forward" for oncology and immunotherapy, but there remains "significant room for differentiated products," H.C. Wainwright analyst Joseph Pantginis tells investors in a research note on Iovance Biotherapeutics (IOVA) titled "Pins Set Up: Kite Acquired and Kymriah Approved; TILs Can Knock 'Em Down; Reiterate Buy." The analyst believes Iovance's TILs, or tumor infiltrating lymphocytes, could be significantly differentiated from CAR-Ts like Kymriah. He says the TIL platform has a "significantly" more benign safety profile relative to CAR-Ts and growing evidence that it could effectively target solid tumors, an area where he thinks CAR-Ts continue to struggle. Pantginis thinks Iovance "fired another shot across the bow of CAR-Ts" with last night's ESMO conference abstracts. The company released preliminary data that it can generate highly active TILs from lymphoma tumors, the analyst contends. He reiterates a Buy rating on Iovance with a $16 price target. The shares closed yesterday down 30c to $5.55.
09/01/17
WELS
09/01/17
NO CHANGE
WELS
Outperform
Iovance fast track designation 'particularly validating,' says Wells Fargo
Wells Fargo analyst Jim Birchenough views Iovance Biotherapeutics' fast track designation from the FDA for its tumor infiltrating lymphocyte product LN-144 as "particularly validating for a novel cell therapy." The designation establishes unmet need for patients and could support a "more reasonable" Phase 3 hurdle, Birchenough tells investors in a research note. He has an Outperform rating on Iovance.
09/13/17
HCWC
09/13/17
NO CHANGE
Target $16
HCWC
Buy
Iovance expanding on multiple fronts, says H.C. Wainwright
Iovance Biotherapeutics released data at ESMO that it can generate highly active tumor infiltrating lymphocytes from lymphoma tumors, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note titled "Targeting Liquid Tumors and Automating the Supply Chain; Iovance Expanding on Multiple Fronts." The analyst says that while clinical efficacy of these expanded TILs remains unknown, he sees "significant safety profile differentiation" when compared to CAR-Ts. He notes that Iovance is also building new partnerships to make the supply chain run more efficiently. Pantginis keeps a Buy rating on the shares with a $16 price target.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$82.25

1.18 (1.46%)

15:19
05/24/18
05/24
15:19
05/24/18
15:19
Hot Stocks
PayPal at session highs, up 2% to $82.63 as CFO presents at investor day »

PayPal CFO John Rainey is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 12

    Jun

GPS

Gap

$32.87

0.9 (2.82%)

15:19
05/24/18
05/24
15:19
05/24/18
15:19
Options
Gap options imply 9.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TMUS

T-Mobile

$57.03

0.01 (0.02%)

15:17
05/24/18
05/24
15:17
05/24/18
15:17
Periodicals
T-Mobile glitch let anyone access customer account data, ZDNet reports »

A glitch in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/24/18
05/24
15:17
05/24/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/24/18
05/24
15:16
05/24/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,605.50

3.73 (0.23%)

15:14
05/24/18
05/24
15:14
05/24/18
15:14
Periodicals
Family claims Amazon device recorded, shared private conversation, Kiro7 says »

A Portland family has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

ADSK

Autodesk

$139.19

-0.11 (-0.08%)

15:04
05/24/18
05/24
15:04
05/24/18
15:04
Options
Autodesk options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

SJM

J.M. Smucker

$109.22

-0.98 (-0.89%)

15:00
05/24/18
05/24
15:00
05/24/18
15:00
Options
Notable spread in JM Smucker »

Notable spread in JM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

  • 15

    Aug

DB

Deutsche Bank

$12.29

-0.605 (-4.69%)

14:58
05/24/18
05/24
14:58
05/24/18
14:58
Periodicals
Deutsche Bank shareholders vote down motion to remove Chairman, Reuters says »

About 91% of Deutsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$61.03

-0.36 (-0.59%)

14:51
05/24/18
05/24
14:51
05/24/18
14:51
Hot Stocks
Total acquires 10% interest in Novatek's Arctic LNG 2 project »

Chairman of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGLD

Internet Gold

$3.38

0.37 (12.29%)

14:49
05/24/18
05/24
14:49
05/24/18
14:49
Technical Analysis
Technical Take: Internet Gold spikes after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$56.05

-0.19 (-0.34%)

14:49
05/24/18
05/24
14:49
05/24/18
14:49
Options
Nutanix options imply 13.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 07

    Jun

  • 10

    Jul

TAHO

Tahoe Resources

$5.11

-0.195 (-3.68%)

14:45
05/24/18
05/24
14:45
05/24/18
14:45
Options
Tahoe Resources call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$72.03

0.71 (1.00%)

, UA

Under Armour

$18.34

0.45 (2.52%)

14:29
05/24/18
05/24
14:29
05/24/18
14:29
Periodicals
Nike to take MLB on-field rights from Under Armour in 2020 season, SBD says »

MLB's on-field…

NKE

Nike

$72.03

0.71 (1.00%)

UA

Under Armour

$18.34

0.45 (2.52%)

UAA

Under Armour

$20.50

0.43 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

IGLD

Internet Gold

$3.22

0.21 (6.98%)

14:25
05/24/18
05/24
14:25
05/24/18
14:25
Earnings
Internet Gold jumps 20% to $3.65 after disclosing Q1 results 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$54.61

-0.145 (-0.26%)

14:20
05/24/18
05/24
14:20
05/24/18
14:20
Options
2X average daily option volume in International Paper and calls lead puts 11:1 »

2X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/24/18
05/24
14:17
05/24/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/24/18
05/24
14:16
05/24/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YNDX

Yandex

$33.72

-0.83 (-2.40%)

14:15
05/24/18
05/24
14:15
05/24/18
14:15
Options
Yandex put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
05/24/18
05/24
14:15
05/24/18
14:15
General news
Fed funds futures have continued to rally »

Fed funds futures have…

OUT

Outfront Media

$19.43

-0.11 (-0.56%)

14:10
05/24/18
05/24
14:10
05/24/18
14:10
Hot Stocks
Outfront Media hires Matthew Siegel for CFO position »

OUTFRONT Media announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
05/24/18
05/24
13:50
05/24/18
13:50
General news
Philly Fed's Harker views a 2019 end to the tightening cycle »

Philly Fed's Harker…

ECA

Encana

$13.12

-0.22 (-1.65%)

13:45
05/24/18
05/24
13:45
05/24/18
13:45
Options
Encana call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

13:45
05/24/18
05/24
13:45
05/24/18
13:45
General news
Breaking General news story  »

Philadelphia Federal…

PYPL

PayPal

$82.17

1.1 (1.36%)

13:41
05/24/18
05/24
13:41
05/24/18
13:41
Hot Stocks
FTC gives final approval to PayPal settlement over Venmo claims »

The Federal Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.